Literature DB >> 12491022

Percutaneous placement of metallic stents in malignant biliary obstruction: one-stage or two-stage procedure? Pre-dilate or not?

Mehmet Inal1, Erol Aksungur, Erol Akgül, Mahmut Oguz, Gülsah Seydaoglu.   

Abstract

The aim of this paper was to evaluate the necessity of percutaneous transhepatic catheter drainage and balloon dilation procedures performed before stent insertion. One hundred and twenty-six patients with unresectable malignant biliary obstruction underwent palliative therapy by means of percutaneous transhepatic placement of 183 metallic biliary endoprotheses. Forty-four (35%) patients underwent metallic stent insertion in a one-stage procedure and 82 (65%) had undergone percutaneous transhepatic catheter drainage before stent insertion. Balloon dilation of the stenosis before stent placement (pre-dilation) was performed in 53 (42%) of 126 patients. The rate of the 30-day mortality was 11%, with no procedure-related deaths. The total rate of early complications was 29%, and 84% of these complications were due to percutaneous transhepatic catheter drainage and pre-dilation procedures. Percutaneous transhepatic catheter drainage and pre-dilation had no clinical or statistically significant effect on the patients' survival and stent patency rate. Percutaneous transhepatic catheter drainage and balloon dilation increased the cost of stent placement 18% and 19%, respectively. Palliation of malignant biliary obstruction with percutaneous transhepatic stent insertion should be done directly, in the simplest way, without performing percutaneous transhepatic catheter drainage and balloon dilation before stent placement. It is more useful, safe, and cost-effective.

Entities:  

Mesh:

Year:  2002        PMID: 12491022     DOI: 10.1007/s00270-002-2647-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.

Authors:  Yi Chen; Xiao-Lin Wang; Zhi-Ping Yan; Jie-Min Cheng; Jian-Hua Wang; Gao-Quan Gong; Sheng Qian; Jian-Jun Luo; Qing-Xin Liu
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

2.  Percutaneous Transhepatic Biliary Stenting with Uncovered Self-Expandable Metallic Stents in Patients with Malignant Biliary Obstruction - Efficacy and Survival Analysis.

Authors:  Andrius Pranculis; Mantas Kievišas; Lina Kievišienė; Artūras Vaičius; Tomas Vanagas; Rytis Stasys Kaupas; Žilvinas Dambrauskas
Journal:  Pol J Radiol       Date:  2017-08-10

3.  Comparing percutaneous primary and secondary biliary stenting for malignant biliary obstruction: A retrospective clinical analysis.

Authors:  Nikolaos Chatzis; Roger Pfiffner; Michael Glenck; Paul Stolzmann; Thomas Pfammatter; Pankaj Sharma
Journal:  Indian J Radiol Imaging       Date:  2013-01

4.  Clinical Performance Status and Technical Factors Affecting Outcomes from Percutaneous Transhepatic Biliary Interventions; A Multicentre, Prospective, Observational Cohort Study.

Authors:  Gregory C Makris; Andrew C Macdonald; Kader Allouni; Hannah Corrigall; Charles R Tapping; Jane Philips Hughes; Suzie Anthony; Phil Boardman; Rafiudin Patel; Andrew Wigham; Mohammad Ali Husainy; Teik Choon See; James Cast; Simon Olliff; Simon Travis; Hans-Ulrich Laasch; Colin Nice; Raman Uberoi
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-12       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.